Butterfly Network, Inc. (NYSE: BFLY), a digital health company known for its portable ultrasound system based on semiconductors and intuitive software, has announced that it has achieved its Certificate of Compliance with the European Medical Device Regulation (EU MDR) for…
Boston Imaging, the U.S. headquarters of Samsung’s digital radiography and ultrasound division, received HHM Health’s Healthcare Innovator Award for its SonoSync technology and efforts to improve healthcare access for underserved communities. The award was accepted during HHM Health’s Healing Hands…
IPA (IMMUNOPRECISE ANTIBODIES LTD.) (NASDAQ: IPA), a biotherapeutics research and technology company driven by artificial intelligence, has acquired Carterra’s LSA® instrument platform. This high-throughput screening and characterization solution enhances IPA’s capabilities in antibody characterization through surface plasmon resonance, enabling advanced…
Bristol Myers Squibb (NYSE: BMY) has announced that the European Commission (EC) has granted approval to Abecma® (idecabtagene vicleucel; ide-cel) for treating adult patients with relapsed and refractory multiple myeloma who have undergone at least two prior therapies, including specific…
Merz Aesthetics, the global leader in medical aesthetics, will showcase fresh data on its product lineup and share insights into trends in medical aesthetics at the 2024 Aesthetic and Anti-Aging Medicine World Congress (AMWC). This prestigious event focuses on cutting-edge…
Takeda (TSE:4502/NYSE:TAK) announced today that the FDA has approved ICLUSIG® (ponatinib) through sNDA for treating adults with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) in combination with chemotherapy. The approval is based on accelerated approval criteria, with confirmation…
SetPoint Medical, a healthcare company focusing on chronic autoimmune diseases, has secured Breakthrough Device Designation from the FDA for its neuroimmune modulation platform aimed at patients with relapsing-remitting multiple sclerosis (RRMS). This designation facilitates interactive communication and priority regulatory review…
908 Devices Inc. (Nasdaq: MASS), known for its portable and desktop devices designed for chemical and biochemical analysis, has announced the adoption of its MX908 device by DrugDetect EU and the NATO Support and Procurement Agency (NSPA). These international contracts…
Fabric Genomics, a pioneer in AI-driven next-generation sequencing interpretation, has announced a fresh collaboration with Intermountain Children’s Health. This partnership aims to analyze whole genomes of children sequenced by Broad Clinical Labs, facilitating faster diagnosis for children suspected of genetic…
Verato, a leading expert in healthcare identity solutions, has announced a collaboration with Google Cloud aimed at empowering healthcare organizations to streamline their operations with a comprehensive enterprise identity data management solution. This partnership addresses the fundamental challenge in healthcare…
LGM Pharma, a prominent provider of customized API and CDMO services throughout the drug product lifecycle, has unveiled major upgrades to its capabilities. This includes a 50% expansion and a substantial investment of over $2 million in its Analytical Testing…
AstraZeneca has initiated a Phase III trial to study the effects of the triple-combination inhaled therapy BREZTRI AEROSPHERE® (budesonide/glycopyrronium/formoterol fumarate, or BGF) on severe cardiopulmonary outcomes in people with chronic obstructive pulmonary disease (COPD). This trial aims to investigate the…